Source: Annual Congress 2010 - Managing asthma and allergic disease in children
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Pavord, N. Thomson, R. Niven, P. Shah, A. Mansor, H. T. ten Hacken (Leicester, Glasgow, Manchester, London, Birmingham, United Kingdom; Groningen, Netherlands). Late Breaking Abstract: Persistent effect of bronchial thermoplasty (BT) in severe asthma at two years. Eur Respir J 2010; 36: Suppl. 54, 2631

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract: Tiotropium improves lung function in patients with severe uncontrolled asthma Source: Annual Congress 2010 - Treatment options for asthma Year: 2010 Late Breaking Abstract - The impact of treatment with mepolizumab on airway remodeling in patients with severe eosinophilic asthma. Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Early response to benralizumab in Canadians with severe eosinophilic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021 Late Breaking Abstract - Gender and asthma: Gender-dependent effects of obesity on allergic pulmonary inflammation Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Safety of bronchial thermoplasty out to 5 years in patients with severe refractory asthma: Research in severe asthma (RISA) trial Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Late Breaking Abstract - Mepolizumab reduces exacerbations in eosinophilic COPD Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017 Late Breaking Abstract - The effects of allergen (DP/DF) on mucociliary transport of allergic rhinitis patients Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses Year: 2019 Late Breaking Abstract - Effect of obesity on progression of smokers without airflow obstruction to COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Late Breaking Abstract - Effect of timapiprant, a DP2 antagonist, on airway inflammation in severe eosinophilic asthma Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Asthma Year: 2019 Late Breaking Abstract - Phenotyping Mepolizumab EXacerbations in severe eosinophilic asthma (MEX) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Late Breaking Abstract - Airway hyperresponsiveness in bronchiectasis Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Late Breaking Abstract - Clinical characteristics and lung function trends of severe eosinophilic asthma patients unresponsive to Mepolizumab Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019 Efficacy of bronchial thermoplasty (BT) in patients with severe asthma: the AIR2 trial Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Late Breaking Abstract - Expiratory variability index (EVI) in young children during asthma exacerbation Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Clinical response of severe asthma patients following Bronchial Thermoplasty. Source: International Congress 2017 – To freeze or heat? Year: 2017 Late Breaking Abstract - EvA consortium: bronchial brush bacterial load is associated with airway remodelling in mild-to-moderate COPD Source: International Congress 2017 – Late-breaking studies in asthma and COPD Year: 2017